Verse Medical key facts
as of Oct 2026- Developer of healthcare software intended to provide reliable, timely, and affordable care for patients in their homes.
- Verse Medical is valued at approximately $772.0M as of Oct 2026 (last reported valuation).
- It has raised $108.1M; the latest was Later Stage VC ($53.0M) in Jun 2025.
- Notable investors include Y Combinator, Soma Capital, Pareto Holdings, Abstract Ventures, FundersClub — 17 tracked in total.
- Status: Privately Held (backing).
Verse Medical's last reported valuation, Jun 2025. Nothing priced has surfaced since.
- ·The complete investor list: 17 names
- ·Watch Verse Medical: the Monday email on marks, rounds and moves
Verse Medical funding rounds
No funding rounds for Verse Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Verse Medical
17+Membership and data by Private Market View
Verse Medical valuation
Verse Medical's last reported valuation was $772 million in Jun 2025. No priced round, secondary trade or fund mark has surfaced since.
Verse Medical investors
17 investors are on record for Verse Medical, including Y Combinator, Soma Capital, Pareto Holdings and Abstract Ventures. By type, the record holds 8 venture capital firms and 3 angel investors.
About Verse Medical
Developer of healthcare software intended to provide reliable, timely, and affordable care for patients in their homes. The company's software provides a robust infrastructure to offer the transition from the hospital to the home or the outpatient center to their homes, enabling patients to receive an in-home care experience seamlessly and healthcare administration and clinicians to save time.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2018
- Employees
- 136
- Website
- versemedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.